Focus Partners Wealth grew its stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 44.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,637,047 shares of the company's stock after acquiring an additional 503,290 shares during the period. Procter & Gamble comprises about 0.8% of Focus Partners Wealth's holdings, making the stock its 28th biggest position. Focus Partners Wealth owned about 0.07% of Procter & Gamble worth $289,457,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Regent Peak Wealth Advisors LLC raised its stake in Procter & Gamble by 1.3% in the 4th quarter. Regent Peak Wealth Advisors LLC now owns 11,063 shares of the company's stock valued at $1,855,000 after purchasing an additional 139 shares during the last quarter. First Hawaiian Bank boosted its position in Procter & Gamble by 1.8% during the fourth quarter. First Hawaiian Bank now owns 8,426 shares of the company's stock worth $1,413,000 after acquiring an additional 147 shares during the last quarter. ORG Partners LLC boosted its position in Procter & Gamble by 5.6% during the fourth quarter. ORG Partners LLC now owns 5,618 shares of the company's stock worth $943,000 after acquiring an additional 300 shares during the last quarter. Avondale Wealth Management raised its holdings in Procter & Gamble by 64.1% in the 4th quarter. Avondale Wealth Management now owns 3,200 shares of the company's stock valued at $536,000 after acquiring an additional 1,250 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Procter & Gamble by 16.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 1,780,064 shares of the company's stock worth $308,308,000 after purchasing an additional 245,863 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Buying and Selling at Procter & Gamble
In other news, CEO Gary A. Coombe sold 18,000 shares of the stock in a transaction on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares in the company, valued at approximately $3,785,274.66. This represents a 44.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the transaction, the chief executive officer now owns 51,965 shares in the company, valued at $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 64,520 shares of company stock valued at $10,999,268 in the last quarter. Corporate insiders own 0.18% of the company's stock.
Procter & Gamble Stock Up 2.6%
NYSE PG traded up $4.09 on Thursday, hitting $162.11. 4,471,769 shares of the stock traded hands, compared to its average volume of 7,200,208. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43. The stock has a 50-day moving average of $164.97 and a 200 day moving average of $167.37. The company has a market capitalization of $380.07 billion, a P/E ratio of 25.81, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. During the same quarter in the prior year, the firm earned $1.52 EPS. The company's revenue for the quarter was down 2.1% compared to the same quarter last year. As a group, analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.61%. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date of this dividend is Monday, April 21st. Procter & Gamble's payout ratio is presently 66.98%.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on the company. JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Wells Fargo & Company lifted their price objective on Procter & Gamble from $176.00 to $180.00 and gave the company an "overweight" rating in a research note on Thursday, January 23rd. Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the stock an "overweight" rating in a research report on Friday, April 25th. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Finally, Erste Group Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Eight research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $178.52.
Read Our Latest Report on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
